Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of AbbVie's Tavapadon?
Tavapadon is a small molecule commercialized by AbbVie, with a leading Phase III program in Parkinson's Disease. According to Globaldata,...
Data Insights
Tavapadon by Cerevel Therapeutics for Parkinson's Disease: Likelihood of Approval
Tavapadon is under clinical development by Cerevel Therapeutics and currently in Phase III for Parkinson's Disease. According to GlobalData, Phase...